AURELIA: Phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancer | Dr Eric Pujade-Lauraine at ECC 2015 - 101271

Spotlight
Video

AURELIA: Phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancer | Dr Eric Pujade-Lauraine at ECC 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: At the European Cancer Congress (ECC) 2015, Eric Pujade-Lauraine, MD, PhD, of Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France, discusses AURELIA, an open-label, randomised, phase 3 clinical trial that was designed to evaluate bevacizumab combined with chemotherapy (pegylated liposomal doxorubicin, weekly paclitaxel or topotecan) for patients with platinum-resistant recurrent ovarian cancer.

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 11/17/15
Added : 4 years ago
Category : Ovarian Cancer